Allied Minds (LSE: ALM) is an early stage investor in technology and life sciences companies underpinned by US scientific innovation. We originate from US federally funded labs, universities and connected entrepreneurs. We invest in potential breakthrough science to disrupt or create large markets, with a particular focus on connectivity, space and medical devices.

HawkEye 360 successful launch of pathfinder satellite cluster

Video - 4 December 2018

Allied Minds portfolio company, HawkEye 360, Inc. (HawkEye 360) today announced the successful launch of the company’s Pathfinder mission


Spin Memory (formerly Spin Transfer Technologies) announces Series B fundraise

RNS -12 November 2018

Commercial agreement with Arm for the licensing of Spin Memory's Endurance Engine design IP to address static random-access memory (SRAM) applications, and a commercial agreement with Applied Materials to create a comprehensive embedded MRAM solution.


HawkEye 360’s SEAker Maritime Domain Awareness Product


Applying HawkEye 360’s proprietary RF detection and analytics capabilities to combat piracy, sanctions violations, human trafficking and other nefarious sea-based activities.


Raytheon Investment in HawkEye 360 and Broader Partnership

Press Release - 10 September 2018

"Our plan is to fuse HawkEye 360's geospatial information with other relevant data sources, further augmenting the intelligence we provide to our U.S. and international customers.”

- Dave Wajsgras, President, Raytheon Intelligence, Information and Services


Focused on the Technology and Life Sciences Sectors

Reports & Presentations

View All

Portfolio News

View All